Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griguolo

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
The Oncologist|March 20, 2023
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapyGrazia Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi, et al.
Breast (Edinburgh, Scotland)|July 30, 2019
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysisGrazia Vernaci, Maria Vittoria Dieci, Silvia Manfrin, et al.
The Oncologist|July 4, 2020
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.
Pathology, Research and Practice|April 7, 2022
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case seriesGiovanni Zarrilli, Valentina Angerilli, Rocco Cappellesso, et al.
The Breast Journal|December 15, 2019
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective studyTommaso Giarratano, Simona Frezzini, Monica Zanocco, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trialValentina Guarneri, Maria V Dieci, Gaia Griguolo, et al.
Breast Cancer Research : BCR|June 23, 2018
Immune characterization of breast cancer metastases: prognostic implicationsMaria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto, et al.
Journal of the National Cancer Institute|September 7, 2023
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancerMaria Vittoria Dieci, PierFranco Conte, Giancarlo Bisagni, et al.
The Oncologist|June 2, 2019
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE StudyMaria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA TrialMaria Vittoria Dieci, Valentina Guarneri, Anna Tosi, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
The Oncologist|March 20, 2023
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapyGrazia Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi, et al.
Breast (Edinburgh, Scotland)|July 30, 2019
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysisGrazia Vernaci, Maria Vittoria Dieci, Silvia Manfrin, et al.
The Oncologist|July 4, 2020
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.
Pathology, Research and Practice|April 7, 2022
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case seriesGiovanni Zarrilli, Valentina Angerilli, Rocco Cappellesso, et al.
The Breast Journal|December 15, 2019
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective studyTommaso Giarratano, Simona Frezzini, Monica Zanocco, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trialValentina Guarneri, Maria V Dieci, Gaia Griguolo, et al.
Breast Cancer Research : BCR|June 23, 2018
Immune characterization of breast cancer metastases: prognostic implicationsMaria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto, et al.
Journal of the National Cancer Institute|September 7, 2023
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancerMaria Vittoria Dieci, PierFranco Conte, Giancarlo Bisagni, et al.
The Oncologist|June 2, 2019
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE StudyMaria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA TrialMaria Vittoria Dieci, Valentina Guarneri, Anna Tosi, et al.
Pageof 14